<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><title>Pharma News from PharmiWeb.com</title><link>http://www.pharmiweb.com/</link><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/Pharmaceutical-News" /><description>Global news and press releases from the Pharmaceutical industry</description><language>en-gb</language><image><link>http://www.Pharmiweb.com</link><url>http://www.pharmiweb.com/images/logos/pweb_logo.gif</url><title>PharmiWeb.com</title></image><copyright>&amp;#169; 1998 - 2012 PharmiWeb Solutions - All Rights Reserved</copyright><lastBuildDate>Thu, 09 Feb 2012 17:00:00 PST</lastBuildDate><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/Pharmaceutical-News" /><feedburner:info uri="pharmaceutical-news" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>Pharmaceutical-News</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><item><title>Voce Capital Sends Letter to Obagi Medical Products Board of Directors</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/HthuD2bwuTc/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Voce Capital Sends Letter to Obagi Medical Products Board of Directors&lt;/strong&gt;&lt;br /&gt;
Voce Capital Management LLC (“Voce”) announced today tha...&lt;br /&gt;Voce Capital Management LLC&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=HthuD2bwuTc:jGndrRYomQQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=HthuD2bwuTc:jGndrRYomQQ:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=HthuD2bwuTc:jGndrRYomQQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=HthuD2bwuTc:jGndrRYomQQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/HthuD2bwuTc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54179</feedburner:origLink></item><item><title>NeuroMetrix, Inc. Announces Date for 2011 Fourth Quarter Financial Results Conference Call</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/QqHKJINmBy4/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;NeuroMetrix, Inc. Announces Date for 2011 Fourth Quarter Financial Results Conference Call&lt;/strong&gt;&lt;br /&gt;
NeuroMetrix, Inc. (Nasdaq: NURO) tod...&lt;br /&gt;NeuroMetrix  Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=QqHKJINmBy4:KsQQA6BQAmI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=QqHKJINmBy4:KsQQA6BQAmI:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=QqHKJINmBy4:KsQQA6BQAmI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=QqHKJINmBy4:KsQQA6BQAmI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/QqHKJINmBy4" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54178</feedburner:origLink></item><item><title>Investment community to come out in full force at BIO-Europe Spring® 2012</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/OrwdKuxPxcY/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Investment community to come out in full force at BIO-Europe Spring® 2012&lt;/strong&gt;&lt;br /&gt;
Biopharm is gearing up for BIO-Europe Spring®, EBD Gr...&lt;br /&gt;EBD Group&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=OrwdKuxPxcY:F6bR22BKi5I:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=OrwdKuxPxcY:F6bR22BKi5I:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=OrwdKuxPxcY:F6bR22BKi5I:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=OrwdKuxPxcY:F6bR22BKi5I:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/OrwdKuxPxcY" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54177</feedburner:origLink></item><item><title>Walgreens Makes Shopping Easier with Additional Online Savings and New Weekly Ad Circular</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/dRufOJwWYxA/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Walgreens Makes Shopping Easier with Additional Online Savings and New Weekly Ad Circular&lt;/strong&gt;&lt;br /&gt;
Walgreens (NYSE: WAG) (NASDAQ: WAG) a...&lt;br /&gt;Walgreens&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=dRufOJwWYxA:8lc-rToeTSE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=dRufOJwWYxA:8lc-rToeTSE:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=dRufOJwWYxA:8lc-rToeTSE:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=dRufOJwWYxA:8lc-rToeTSE:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/dRufOJwWYxA" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54176</feedburner:origLink></item><item><title>XenoPort to Present at the Leerink Swann Global Healthcare Conference</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/hIvdPCDr1fw/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;XenoPort to Present at the Leerink Swann Global Healthcare Conference&lt;/strong&gt;&lt;br /&gt;
XenoPort, Inc. (Nasdaq:XNPT) announced today that it will...&lt;br /&gt;XenoPort  Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=hIvdPCDr1fw:mg2sDp3rupQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=hIvdPCDr1fw:mg2sDp3rupQ:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=hIvdPCDr1fw:mg2sDp3rupQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=hIvdPCDr1fw:mg2sDp3rupQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/hIvdPCDr1fw" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54173</feedburner:origLink></item><item><title>CardioNet, Inc. Acquires ECG Scanning &amp; Medical Services, Inc.</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/Bg3KrM5VGxU/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;CardioNet, Inc. Acquires ECG Scanning &amp;amp; Medical Services, Inc.&lt;/strong&gt;&lt;br /&gt;
CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical te...&lt;br /&gt;CardioNet  Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Bg3KrM5VGxU:oYwHcvqYG3c:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Bg3KrM5VGxU:oYwHcvqYG3c:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Bg3KrM5VGxU:oYwHcvqYG3c:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=Bg3KrM5VGxU:oYwHcvqYG3c:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/Bg3KrM5VGxU" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54172</feedburner:origLink></item><item><title>Alexion to Present at the Leerink Swann 2012 Global Healthcare Conference</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/6eo4STEG03E/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Alexion to Present at the Leerink Swann 2012 Global Healthcare Conference&lt;/strong&gt;&lt;br /&gt;
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today an...&lt;br /&gt;Alexion Pharmaceuticals  Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=6eo4STEG03E:M_LUihMfB0I:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=6eo4STEG03E:M_LUihMfB0I:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=6eo4STEG03E:M_LUihMfB0I:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=6eo4STEG03E:M_LUihMfB0I:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/6eo4STEG03E" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54171</feedburner:origLink></item><item><title>Company Profile for Clovis Oncology</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/3AVTheHMucE/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Company Profile for Clovis Oncology&lt;/strong&gt;&lt;br /&gt;
Clovis Oncology, Inc. is a biopharmaceutical company focused on 
acquiring, developing and ...&lt;br /&gt;Clovis Oncology&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=3AVTheHMucE:OYbQbOd89LY:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=3AVTheHMucE:OYbQbOd89LY:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=3AVTheHMucE:OYbQbOd89LY:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=3AVTheHMucE:OYbQbOd89LY:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/3AVTheHMucE" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54170</feedburner:origLink></item><item><title>Gilead Sciences to Present at Two Upcoming Investor Conferences</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/OfWFtDjShbg/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Gilead Sciences to Present at Two Upcoming Investor Conferences &lt;/strong&gt;&lt;br /&gt;Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John ...&lt;br /&gt;Gilead Sciences, Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=OfWFtDjShbg:4cA9VkAsCk8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=OfWFtDjShbg:4cA9VkAsCk8:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=OfWFtDjShbg:4cA9VkAsCk8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=OfWFtDjShbg:4cA9VkAsCk8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/OfWFtDjShbg" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54169</feedburner:origLink></item><item><title>Research and Markets: Biomedical Materials Subscription - Reports on New and Existing Application Areas</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/stWp6QT4P0g/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Research and Markets: Biomedical Materials Subscription - Reports on New and Existing Application Areas&lt;/strong&gt;&lt;br /&gt;Research and Markets(htt...&lt;br /&gt;Research and Markets&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=stWp6QT4P0g:7IkrDvaUItA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=stWp6QT4P0g:7IkrDvaUItA:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=stWp6QT4P0g:7IkrDvaUItA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=stWp6QT4P0g:7IkrDvaUItA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/stWp6QT4P0g" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54168</feedburner:origLink></item><item><title>Laboratory Corporation of America® Holdings Announces 2011 Fourth Quarter and Full Year Results</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/vsxZ7GIqHU0/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Laboratory Corporation of America® Holdings Announces 2011 Fourth Quarter and Full Year Results&lt;/strong&gt;&lt;br /&gt;
Laboratory Corporation of Ameri...&lt;br /&gt;Laboratory Corporation of America(R) Holdings&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=vsxZ7GIqHU0:cjzJPGPPmVc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=vsxZ7GIqHU0:cjzJPGPPmVc:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=vsxZ7GIqHU0:cjzJPGPPmVc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=vsxZ7GIqHU0:cjzJPGPPmVc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/vsxZ7GIqHU0" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54167</feedburner:origLink></item><item><title>Nodality and UCB Enter into a Multi-Year Strategic Collaboration</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/3w8rSbb4cNs/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Nodality and UCB Enter into a Multi-Year Strategic Collaboration&lt;/strong&gt;&lt;br /&gt;
Nodality, Inc. and UCB Pharma S.A. (Euronext Brussels: UCB) to...&lt;br /&gt;Nodality  Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=3w8rSbb4cNs:6n-7tUV9BOo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=3w8rSbb4cNs:6n-7tUV9BOo:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=3w8rSbb4cNs:6n-7tUV9BOo:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=3w8rSbb4cNs:6n-7tUV9BOo:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/3w8rSbb4cNs" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54166</feedburner:origLink></item><item><title>Home Care Software Solutions, Inc. Announces Launch of EDI Smart Reader</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/Jp73OyhGzc8/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Home Care Software Solutions, Inc. Announces Launch of EDI Smart Reader&lt;/strong&gt;&lt;br /&gt;PR NewswireCARY, N.C., Feb. 10, 2012CARY, N.C., Feb. 10,...&lt;br /&gt;ERELEASES&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Jp73OyhGzc8:GFhiEqhlSgA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Jp73OyhGzc8:GFhiEqhlSgA:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Jp73OyhGzc8:GFhiEqhlSgA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=Jp73OyhGzc8:GFhiEqhlSgA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/Jp73OyhGzc8" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54165</feedburner:origLink></item><item><title>Exelixis Announces Pricing of $60.5 Million Public Offering of Common Stock</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/Hx0gN06Ol2Y/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Exelixis Announces Pricing of $60.5 Million Public Offering of Common Stock&lt;/strong&gt;&lt;br /&gt;
Exelixis, Inc. (Nasdaq:EXEL) today announced the pr...&lt;br /&gt;Exelixis  Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Hx0gN06Ol2Y:FGD69u4n52A:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Hx0gN06Ol2Y:FGD69u4n52A:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Hx0gN06Ol2Y:FGD69u4n52A:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=Hx0gN06Ol2Y:FGD69u4n52A:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/Hx0gN06Ol2Y" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54164</feedburner:origLink></item><item><title>Taro Provides Preliminary 2011 Full Year and Q4 Results</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/HNvhcuDVprg/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Taro Provides Preliminary 2011 Full Year and Q4 Results&lt;/strong&gt;&lt;br /&gt;
Taro Pharmaceutical Industries Ltd. (“Taro,” or the “Company,” Pink 
Sh...&lt;br /&gt;Taro Pharmaceutical Industries Ltd.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=HNvhcuDVprg:68LzQ_hV_lc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=HNvhcuDVprg:68LzQ_hV_lc:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=HNvhcuDVprg:68LzQ_hV_lc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=HNvhcuDVprg:68LzQ_hV_lc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/HNvhcuDVprg" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54163</feedburner:origLink></item><item><title>Strategic Drug Development and Consulting Practices Provide Knowledge-Based Approach</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/vahnGsPWRIU/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Strategic Drug Development and Consulting Practices Provide Knowledge-Based Approach&lt;/strong&gt;&lt;br /&gt;To help biopharmaceutical companies navigat...&lt;br /&gt;Quintiles&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=vahnGsPWRIU:I21mQSXSMrU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=vahnGsPWRIU:I21mQSXSMrU:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=vahnGsPWRIU:I21mQSXSMrU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=vahnGsPWRIU:I21mQSXSMrU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/vahnGsPWRIU" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54158</feedburner:origLink></item><item><title>Boehringer Ingelheim launches 'Lean-to-Clinic' program for fast drug product supply</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/Le0x7_v2JvI/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Boehringer Ingelheim launches &amp;apos;Lean-to-Clinic&amp;apos; program for fast drug product supply&lt;/strong&gt;&lt;br /&gt;Boehringer Ingelheim has expanded ...&lt;br /&gt;Boehringer Ingelheim&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Le0x7_v2JvI:A5J-WCovjs4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Le0x7_v2JvI:A5J-WCovjs4:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=Le0x7_v2JvI:A5J-WCovjs4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=Le0x7_v2JvI:A5J-WCovjs4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/Le0x7_v2JvI" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54157</feedburner:origLink></item><item><title>GSK joins new global partnership to help defeat ten neglected tropical diseases by 2020</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/izVgOoXsa68/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;GSK joins new global partnership to help defeat ten neglected tropical diseases by 2020&lt;/strong&gt;&lt;br /&gt;GlaxoSmithKline (GSK) today announced it...&lt;br /&gt;GlaxoSmithKline&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=izVgOoXsa68:u4tYV0_2VQo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=izVgOoXsa68:u4tYV0_2VQo:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=izVgOoXsa68:u4tYV0_2VQo:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=izVgOoXsa68:u4tYV0_2VQo:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/izVgOoXsa68" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54156</feedburner:origLink></item><item><title>Lundbeck strengthens its European organization</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/zU6tsjU-TpI/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Lundbeck strengthens its European organization&lt;/strong&gt;&lt;br /&gt;Lundbeck bolsters its European organization with the appointment of João Rocha an...&lt;br /&gt;Lundbeck&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=zU6tsjU-TpI:dpbJTpW_Sic:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=zU6tsjU-TpI:dpbJTpW_Sic:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=zU6tsjU-TpI:dpbJTpW_Sic:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=zU6tsjU-TpI:dpbJTpW_Sic:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/zU6tsjU-TpI" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54155</feedburner:origLink></item><item><title>Release of FDA Guidance for Biosimilars Pathway Marks Important Step Forward, Says BIO</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/1_o5JN58FU4/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Release of FDA Guidance for Biosimilars Pathway Marks Important Step Forward, Says BIO&lt;/strong&gt;&lt;br /&gt;
Biotechnology Industry Organization (BIO...&lt;br /&gt;BIO&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=1_o5JN58FU4:Qa4VGsf1ApY:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=1_o5JN58FU4:Qa4VGsf1ApY:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=1_o5JN58FU4:Qa4VGsf1ApY:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=1_o5JN58FU4:Qa4VGsf1ApY:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/1_o5JN58FU4" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54154</feedburner:origLink></item><item><title>Ironwood Pharmaceuticals Prices Public Offering of Common Stock</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/ibaRIx-LLYY/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Ironwood Pharmaceuticals Prices Public Offering of Common Stock&lt;/strong&gt;&lt;br /&gt;
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) (the “Company”) a...&lt;br /&gt;Ironwood Pharmaceuticals  Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ibaRIx-LLYY:1_WrSctRQQA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ibaRIx-LLYY:1_WrSctRQQA:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ibaRIx-LLYY:1_WrSctRQQA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=ibaRIx-LLYY:1_WrSctRQQA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/ibaRIx-LLYY" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54153</feedburner:origLink></item><item><title>Osiris Therapeutics Provides Update Regarding the Genzyme/Sanofi Relationship</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/ixtp6pkeZFc/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Osiris Therapeutics Provides Update Regarding the Genzyme/Sanofi Relationship&lt;/strong&gt;&lt;br /&gt;Osiris 
Therapeutics, Inc. (NASDAQ: OSIR), today p...&lt;br /&gt;Osiris Therapeutics  Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ixtp6pkeZFc:0SrL0FxTuno:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ixtp6pkeZFc:0SrL0FxTuno:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=ixtp6pkeZFc:0SrL0FxTuno:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=ixtp6pkeZFc:0SrL0FxTuno:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/ixtp6pkeZFc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54152</feedburner:origLink></item><item><title>First Birth Defect Complaint Filed in Philadelphia for Anti-Depressant Drug</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/iK7sPYZ8CzQ/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;First Birth Defect Complaint Filed in Philadelphia for Anti-Depressant Drug&lt;/strong&gt;&lt;br /&gt;
Today, in the Philadelphia Court of Common Pleas, s...&lt;br /&gt;Anapol Schwartz&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=iK7sPYZ8CzQ:DyPH5P1raZw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=iK7sPYZ8CzQ:DyPH5P1raZw:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=iK7sPYZ8CzQ:DyPH5P1raZw:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=iK7sPYZ8CzQ:DyPH5P1raZw:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/iK7sPYZ8CzQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54151</feedburner:origLink></item><item><title>Array BioPharma to Present at the Leerink Swann Global Healthcare Conference</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/XOu0MLGQhRA/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Array BioPharma to Present at the Leerink Swann Global Healthcare Conference&lt;/strong&gt;&lt;br /&gt;
Array BioPharma Inc. (Nasdaq: ARRY) today announce...&lt;br /&gt;Array BioPharma&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=XOu0MLGQhRA:Qksa6zuzHqw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=XOu0MLGQhRA:Qksa6zuzHqw:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=XOu0MLGQhRA:Qksa6zuzHqw:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=XOu0MLGQhRA:Qksa6zuzHqw:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/XOu0MLGQhRA" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54150</feedburner:origLink></item><item><title>Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/okxBBMJpLo0/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results&lt;/strong&gt;&lt;br /&gt;
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY...&lt;br /&gt;Alnylam Pharmaceuticals  Inc.&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=okxBBMJpLo0:KHmDXLrXtmk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=okxBBMJpLo0:KHmDXLrXtmk:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=okxBBMJpLo0:KHmDXLrXtmk:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=okxBBMJpLo0:KHmDXLrXtmk:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/okxBBMJpLo0" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54149</feedburner:origLink></item><item><title>Will California Finally Legalize Marijuana? Study Shows 62% of California Voters Polled Favor Legalization</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/akRNqgqxHmc/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Will California Finally Legalize Marijuana? Study Shows 62% of California Voters Polled Favor Legalization&lt;/strong&gt;&lt;br /&gt;
In November, 2010, a...&lt;br /&gt;Regulate Marijuana Like Wine&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=akRNqgqxHmc:QGD6455wxKk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=akRNqgqxHmc:QGD6455wxKk:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=akRNqgqxHmc:QGD6455wxKk:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=akRNqgqxHmc:QGD6455wxKk:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/akRNqgqxHmc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54148</feedburner:origLink></item><item><title>Arrowhead Reports Fiscal 2012 First Quarter Financial Results</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/7fUUg6uzcQs/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Arrowhead Reports Fiscal 2012 First Quarter Financial Results&lt;/strong&gt;&lt;br /&gt;Arrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine 
com...&lt;br /&gt;Arrowhead Research Corporation&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=7fUUg6uzcQs:AUAU68qtGhw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=7fUUg6uzcQs:AUAU68qtGhw:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=7fUUg6uzcQs:AUAU68qtGhw:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=7fUUg6uzcQs:AUAU68qtGhw:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/7fUUg6uzcQs" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54147</feedburner:origLink></item><item><title>CEL-SCI Corporation Reports First Quarter 2012 Financial Results</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/AldiYuEbFqc/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;CEL-SCI Corporation Reports First Quarter 2012 Financial Results&lt;/strong&gt;&lt;br /&gt;
CEL-SCI Corporation (NYSE AMEX: CVM) reports financial results...&lt;br /&gt;CEL-SCI Corporation&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=AldiYuEbFqc:8sEO0mm-fso:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=AldiYuEbFqc:8sEO0mm-fso:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=AldiYuEbFqc:8sEO0mm-fso:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=AldiYuEbFqc:8sEO0mm-fso:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/AldiYuEbFqc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54146</feedburner:origLink></item><item><title>Branham Law Group Investigates Pfizer for Qualitest Packaging Error Recall</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/8zLasQvr0SQ/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Branham Law Group Investigates Pfizer for Qualitest Packaging Error Recall&lt;/strong&gt;&lt;br /&gt;Branham 
Law Group, LLP, a Dallas, Texas law firm, is...&lt;br /&gt;Branham Law Group  LLP&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=8zLasQvr0SQ:9YcDB6FhJ9Y:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=8zLasQvr0SQ:9YcDB6FhJ9Y:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=8zLasQvr0SQ:9YcDB6FhJ9Y:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=8zLasQvr0SQ:9YcDB6FhJ9Y:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/8zLasQvr0SQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54145</feedburner:origLink></item><item><title>Alkermes’ Corporate Presentation to be Webcast at the Leerink Swann 2012 Global Healthcare Conference</title><link>http://feedproxy.google.com/~r/Pharmaceutical-News/~3/t4lJM7n83lw/pressrel.asp</link><pubDate>Thu, 09 Feb 2012 17:00:00 PST</pubDate><description>&lt;strong&gt;Alkermes’ Corporate Presentation to be Webcast at the Leerink Swann 2012 Global Healthcare Conference&lt;/strong&gt;&lt;br /&gt;Alkermes 
plc (NASDAQ: ALK...&lt;br /&gt;Alkermes plc&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=t4lJM7n83lw:5EVx3tHvpXc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=t4lJM7n83lw:5EVx3tHvpXc:7Q72WNTAKBA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?d=7Q72WNTAKBA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/Pharmaceutical-News?a=t4lJM7n83lw:5EVx3tHvpXc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/Pharmaceutical-News?i=t4lJM7n83lw:5EVx3tHvpXc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/Pharmaceutical-News/~4/t4lJM7n83lw" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=54144</feedburner:origLink></item></channel></rss>

